TrialThe British journal of ophthalmology2024

Comparative assessment of subretinal hyper-reflective material in patients treated with brolucizumab versus aflibercept in HAWK and HARRIER.

SriniVas Sadda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.